October/November #191 : Treatment: Normal Mortality Risk if Undetectable? - by Benjamin Ryan

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Features

¡El SIDA Sí Da!

Cut to Fit

From the Editor

Rie y Llora

Feedback

Letters-October/November 2013

The POZ Q+A

Unidos Podemos

POZ Planet

Thank You, Sean Sasser

On the March

Get Lucky

Friend Request

Then There Were None

Why Should Gay and Bi Latino Men Get Tested?

Say What? Zombie Edition

Voices

Obamacare is Here

Care and Treatment

Reduced Dose of Sustiva Succeeds

New Ways to Beat Gonorrhea

Lower Bone Density Linked to Number of ARV Regimens

No Detectable HIV in Two Men After Stem Cell Transplants

WHO Revises Treatment Guidelines

Research Notes

Prevention: HIV Test May Help Improve Vaccines

Treatment: Normal Mortality Risk if Undetectable?

Cure: Cord Blood Transplant Aftermath

Concerns: Early Treatment in Developing World

POZ Heroes

A Test of Kindness

   
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

October / November 2013

Treatment: Normal Mortality Risk if Undetectable?

by Benjamin Ryan

HIV-positive people with a CD4 count of at least 500 and a fully suppressed viral load as a result of antiretroviral treatment appear to have no increased risk of death when compared with their HIV-negative peers. Researchers analyzed data from two large, randomized controlled trials including 3,280 HIV-positive adults who had a low viral load and CD4s above 350 but did not inject drugs. Study participants were followed an average of 3.7 years; 61 people died during the study. The most common causes were cardiovascular disease or sudden death (19 people, or 31 percent) and non-AIDS cancers (12 people, 19 percent). Only two deaths (3 percent) were related to AIDS. For those with CD4s between 350 and 499, there was an estimated 77 percent increased risk of death compared with the general population. However, there was no mortality risk linked with having a CD4 count above 500 and an undetectable viral load.

Search: mortality risk, undetectable, suppressed viral load

Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dave41
    Bethany
    Oklahoma


    usuallyhappy
    Palm Springs
    California


    OahuAJ
    Glendora
    California


    jap022964
    el dorado
    Arkansas
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Is HIV/AIDS adequately portrayed in pop culture?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.